Page 28 - EJMO-9-3
P. 28

Eurasian Journal of
            Medicine and Oncology                                            Role of common CXC chemokines in NAFLD



            development of HCC.  As a result, globally, NAFLD is   beyond the superficial histopathologic similarities to
                              4
            rapidly escalating as the leading cause of liver-related deaths   alcohol-induced liver disease,  in 2020, a global group of
                                                                                       13
            and is becoming a critical factor for terminal liver disease,   specialists formulated a more fitting terminology for the
            primary liver cancer, and liver transplants. Although viral   disease: metabolic dysfunction-associated fatty liver disease
            hepatitis remains the major cause of death from chronic   (MAFLD). In addition, the expert consensus emphasizes
            liver disease, its deleterious effects are dwindling each year   the important role of systemic metabolic dysregulation in
            as the prevalence of hepatitis C virus declines worldwide; in   driving liver disease and proposes a series of simple positive
            contrast, NAFLD has evolved to become the primary cause   criteria for  the  diagnosis  and  evaluation  of  MAFLD.
                                                                                                            14
            of chronic liver disease and needs more attention from   Diagnostically, however, the most significant difference
            society.  At present, invasive liver biopsy cytology is still the   between NAFLD and MAFLD is not the dysregulation of
                  5
            “gold standard” for diagnosing NAFLD,  but popularizing   metabolic pathways, but rather whether or not concomitant
                                            6
            this test in clinics is difficult, which leads to many patients   liver disease is excluded. In summary, NAFLD tends to be an
            being diagnosed with NAFLD at a more severe stage; in   exclusionary diagnosis, whereas MAFLD is more focused
            addition, since the pathophysiology of NAFLD is affected   on telling us what the disease is. 14,15  This change has helped
            by numerous metabolic, genetic, and microbiome factors,   physicians to be able to recognize and treat all of the diseases
            the underlying mechanisms of NAFLD remain largely   of the liver in a holistic way in some patients. In comparison
            unclear, leading to a scarcity of specific drugs to treat the   to NAFLD, studies have found that the use of MAFLD
            disease. 7                                         increases the identification of individuals with high-risk
              The development of NAFLD can be described with   features for progressive liver disease, and its relatively simple
                                                      8
            a multiple-hit model involving multiple stressors,  and   diagnosis facilitates awareness and understanding of the
            although the underlying mechanisms of hepatocellular   disease by clinicians other than hepatologists, facilitating
            steatosis are well elucidated, the pathogenesis of NASH   early  management  of  the disease. 16,17   The  term  “non-
            remains elusive. It is certain that during the development   alcoholic” has been used for more than 40 years since it was
            of NAFLD, disorders of lipid metabolism lead to the   first coined in 1980, and the introduction of MAFLD has
            production of lipotoxic lipids, which induce cellular stress   had the effect of undermining public understanding of the
            (including oxidative stress and endoplasmic reticulum   two diseases; moreover, a proportion of patients who meet
            stress), activation of inflammatory vesicles, and apoptotic   the diagnostic criteria for NAFLD but have no metabolic
            cell death, as well as subsequent inflammatory stimulation,   risk factors have been identified as being at high risk for
            tissue regeneration, and fibrosis, in which inflammatory and   MAFLD. Most importantly, MAFLD has been proposed
            pro-fibrotic macrophages are implicated in the progression   for a relatively short period of time and its research data is
            of liver fibrosis.  Inflammatory factors are a major driving   significantly less compared to NAFLD, so the main body
                        9
            force in the development of non-alcoholic steatohepatitis   of  the discussion  in  this article  places  a  bigger focus  on
            and liver fibrosis, which in turn is a substantial predictor   NAFLD.
            of liver-related morbidity and mortality, thus, there is great   While the early stages of NAFLD show only simple
            clinical potential to reverse the progression of NASH by   steatosis of the liver cells, the progressive stages of NASH
            modulating inflammatory factors.  The interplay between   result in liver cell damage and inflammation, and the
                                       10
            chemokines and their respective receptors is recognized   histologic features of NASH are the presence of liver cell
            as a crucial element in the evolution from simple steatosis   ballooning and inflammation in the liver lobes in addition
            to steatohepatitis,  in which the CXC chemokine family-  with liver steatosis.  Overnutrition is  a major driver of
                          11
                                                                               18
            mediated inflammatory response is highly relevant in the   NAFLD. Excessive intake of energy-dense substances
            pathogenesis of NAFLD, and there exists a considerable   such as fats and carbohydrates leads to dilation of adipose
            research potential for the diagnosis and treatment of   depots and accumulation of ectopic fat. In this context,
            NAFLD.                                             macrophage infiltration into visceral tissues creates a pro-
                                                               inflammatory state that further promotes insulin resistance.
            2. Definitions and pathogenesis                    Insulin resistance promotes free fatty acid transport to
            NAFLD is metabolic disease that is closely associated   the liver, ultimately leading to dysregulation of lipid
            with insulin resistance and genetic susceptibility.  With   metabolism and further development of lipotoxic lipids,
                                                    12
            the understanding of the disease and the need for clinical   causing intracellular oxidative and endoplasmic reticulum
            diagnosis, many clinicians and researchers find it difficult   stress, inflammatory vesicle activation, and apoptotic cell
            to meet the clinical, scientific, and patient needs of NAFLD   death, resulting in hepatocellular injury and development
            as a traditional generic term. To more accurately reflect the   of  hepatic  inflammation.   However,  these  pathways  in
                                                                                   9,12
            pathogenesis of the disease and to expand the terminology   NAFLD are influenced by numerous metabolic, genetic,

            Volume 9 Issue 3 (2025)                         20                              doi: 10.36922/ejmo.8383
   23   24   25   26   27   28   29   30   31   32   33